Skip to content

A two-way cohort study of the total management of esophageal cancer

A two-way cohort study of the total management of esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113314
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Observation Group for the whole-course Management of Esophageal cancer:None

Sponsors

Mianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age =18 years old; 2.Pathologically or clinically diagnosed esophageal cancer; 3. Patients who can fully understand the content of this study, can self-report their symptoms, and have the ability to comply with the follow-up of the study plan, sign the informed consent form, and voluntarily participate in this study. Patients who fulfill the above 3 items at the same time can be included in this study.

Exclusion criteria

Exclusion criteria: 1. Age < 18 years old; 2. Have a history of cognitive impairment and mental illness; Patients who meet any one of the above conditions will be excluded.

Design outcomes

Primary

MeasureTime frame
Overall survival ;

Countries

China

Contacts

Public ContactWu Danfeng

Mianyang Central Hospital

825881013@qq.com+86 816 269 4544

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026